Registered entities
Ngm Biopharmaceuticals Inc
Reg. No. 1426332United States
Ngm Biopharmaceuticals, Inc.
Reg. No. 261679911United States
Innovation
73 patent families (31 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 19,972 times.
| Year | Filings |
|---|---|
| 2015 | 11 |
| 2016 | 19 |
| 2017 | 20 |
| 2018 | 22 |
| 2019 | 24 |
| 2020 | 29 |
| 2021 | 30 |
| 2022 | 22 |
| 2023 | 27 |
| 2024 | 12 |
| 2025 | 12 |
| 2026 | 3 |
Social engagement
Social engagement: 10.7K social following, 2 posts in the last 12 months — around the industry typical range.
Investor mix
9 investors on record; lead investors include Prospect Venture Partners, Rho Capital Partners, Topspin Consumer Partners, The Column Group.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 78% |
| Private equity | 1 | 11% |
| Other / undisclosed | 1 | 11% |
Recent activity
1 Aug 2025
Partnership
PSS